X. Ling, R. J. Bernacki, M. G. Brattain and F. Li. (2004) Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. J Biol Chem; 279: (5)196-203.
 M. Pennati, M. Binda, M. De Cesare, G. Pratesi, M. Folini, L. Citti, M. G. Daidone, F. Zunino and N. Zaffaroni. (2004) Ri-bozyme-mediated down-regulation of survivin expression sensi-tizes human melanoma cells to topotecan in vitro and in vivo. Carcinogenesis; 25: 1129-1136.
 M. Kappler, M. Bache, F. Bartel, M. Kotzsch, M. Panian, P. Wurl, K. Blumke, H. Schmidt, A. Meye and H. Taubert. (2004) Knock-down of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independ-ently of p53. Cancer Gene Ther, 11: 186-193.
 M .Kappler, H. Taubert, F. Bartel, K. Blumke, M. Panian, H. Schmidt, J. Dunst and M. Bache. (2005) Radiosensitization, after a combinedtreatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wtp53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. Oncol Rep, 13: 167-172.
 M. Chawla-Sarkar, S. I. Bae, F. J. Reu, B. S. Jacobs, D. J. Lindner and E. C. Borden. (2004) Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ, 11: 915-923.
 S. Coma, V. Noe, C. Lavarino, J. Adan, M. Rivas, M. Lo-pez-Matas, R. Pagan, F. Mitjans, S. Vilaro, J. Piulats and C. J. Ciudad; (2004) Use of siRNAs and antisense oligonucleo -tides against survivin RNA to inhibit steps leading to tumor angiogene-sis. Oligonucleotides, 14: 100-113.